Jasper Therapeutics, Inc. (JSPR)
NASDAQ: JSPR · Real-Time Price · USD
0.4610
-0.0405 (-8.08%)
Jun 23, 2026, 9:31 AM EDT - Market open
Jasper Therapeutics Employees
Jasper Therapeutics had 22 employees as of December 31, 2025. The number of employees decreased by 42 or -65.63% compared to the previous year.
Employees
22
Change
-42
Growth
-65.63%
Revenue / Employee
n/a
Profits / Employee
-$2,533,364
Market Cap
12.91M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 22 | -42 | -65.63% |
| Sep 30, 2025 | 27 | -37 | -57.81% |
| Dec 31, 2024 | 64 | 19 | 42.22% |
| Dec 31, 2023 | 45 | 10 | 28.57% |
| Dec 31, 2022 | 35 | 10 | 40.00% |
| Sep 30, 2022 | 36 | 14 | 63.64% |
| Jun 30, 2022 | 35 | 11 | 45.83% |
| Mar 31, 2022 | 34 | 12 | 54.55% |
| Dec 31, 2021 | 25 | 3 | 13.64% |
| Sep 30, 2021 | 22 | - | - |
| Jun 30, 2021 | 24 | - | - |
| Mar 31, 2021 | 22 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Quince Therapeutics | 38 |
| BioLineRx | 24 |
| OSR Holdings | 22 |
| IN8bio | 18 |
| SeaStar Medical Holding | 17 |
| BioVie | 13 |
| Cocrystal Pharma | 10 |
| Lexaria Bioscience | 7 |
JSPR News
- 8 days ago - Jasper Therapeutics Proxy statement: Proxy filing - Filings
- 8 days ago - Jasper Therapeutics Proxy statement: Proxy filing - Filings
- 22 days ago - Jasper Therapeutics initiates review of strategic alternatives - TheFly
- 22 days ago - Jasper Therapeutics Announces Exploration of Strategic Alternatives to Maximize Shareholder Value - GlobeNewsWire
- 5 weeks ago - Jasper Therapeutics price target lowered to $3 from $4 at RBC Capital - TheFly
- 5 weeks ago - Jasper Therapeutics downgraded to Hold from Buy at TD Cowen - TheFly
- 5 weeks ago - Jasper Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 5 weeks ago - Jasper Therapeutics Quarterly report: Q1 2026 - Filings